Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases. | Front Physiol | 2021 | 34566674 | PubTator, text mining | PubMed |
| WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections. | World J Emerg Surg | 2021 | 34563232 | PubTator, text mining | PubMed |
| Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials. | PLoS One | 2021 | 34559824 | PubTator, text mining | PubMed |
| Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremia. | ESC Heart Fail | 2021 | 34554640 | PubTator, text mining | PubMed |
| Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and Management. | Cureus | 2021 | 34540466 | PubTator, text mining | PubMed |
| Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry. | Kidney Int Rep | 2021 | 34514208 | PubTator, text mining | PubMed |
| Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD. | Kidney Int Rep | 2021 | 34514204 | PubTator, text mining | PubMed |
| Vasopressin but Not Oxytocin Responds to Birth Stress in Infants. | Front Neurosci | 2021 | 34512251 | PubTator, text mining | PubMed |
| Frequent contiguous pattern mining over biological sequences of protein misfolded diseases. | BMC Bioinformatics | 2021 | 34511072 | PubTator, text mining | PubMed |
| Brain areas affected by intranasal oxytocin show higher oxytocin receptor expression. | Eur J Neurosci | 2021 | 34498316 | PubTator, text mining | PubMed |
| Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2. | Microbiol Spectr | 2021 | 34494876 | PubTator, text mining | PubMed |
| Hormone resistance in children: what primary care physicians need to know. | Acta Biomed | 2021 | 34487068 | PubTator, text mining | PubMed |
| Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease. | FASEB J | 2021 | 34486176 | PubTator, text mining | PubMed |
| A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients. | Pharmacol Res | 2021 | 34481973 | PubTator, text mining | PubMed |
| The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial. | Sci Rep | 2021 | 34480075 | PubTator, text mining | PubMed |
| Comparison and Analysis on the Existing Single-Herbal Strategies against Viral Myocarditis. | Genet Res (Camb) | 2021 | 34456633 | PubTator, text mining | PubMed |
| Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease. | Viruses | 2021 | 34452405 | PubTator, text mining | PubMed |
| Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease. | Int J Mol Sci | 2021 | 34445719 | PubTator, text mining | PubMed |
| Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis. | Evid Based Complement Alternat Med | 2021 | 34408783 | PubTator, text mining | PubMed |
| Chloride in Heart Failure Syndrome: Its Pathophysiologic Role and Therapeutic Implication. | Cardiol Ther | 2021 | 34398440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=37